Laura G. Eichorn
Founder bei IMAGO BIOSCIENCES, INC.
Aktive Positionen von Laura G. Eichorn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Founder | 01.03.2012 | - |
| Director of Finance/CFO | - | - | |
| Chief Operating Officer | - | 24.03.2022 |
Karriereverlauf von Laura G. Eichorn
Ehemalige bekannte Positionen von Laura G. Eichorn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Chief Operating Officer | 01.01.2007 | - |
| Director of Finance/CFO | 01.01.2007 | - | |
| Corporate Officer/Principal | - | - |
Ausbildung von Laura G. Eichorn
| Frostburg State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Operating Officer | 2 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Börse
- Insiders
- Laura G. Eichorn
- Erfahrung
